3.46  0.01 (0.29%)		09-19 12:58
Open: 3.49 High: 3.49 Volume: 39,845		Pre. Close: 3.45 Low: 3.38 Market Cap: 59(M)

Short term
Mid term
Targets	6-month :	4.14	1-year :	4.84
Resists	First :	3.54	Second :	4.14
Pivot price	3.22
Supports	First :	3.2	Second :	2.99
MAs	MA(5) :	3.35	MA(20) :	3.25
	MA(100) :	3.37	MA(250) :	0
MACD	MACD :	0	Signal :	-0.1
%K %D	K(14,3) :	92.4	D(3) :	77.7
RSI	RSI(14): 58.6
52-week	High :	6.25	Low :	2.88

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ MURA ] has closed below upper band by 5.5%. Bollinger Bands are 1.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	3.49 - 3.51	3.51 - 3.52
Low:	3.27 - 3.28	3.28 - 3.3
Close:	3.43 - 3.45	3.45 - 3.47

Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. The company was incorporated in 2017 and is based in Dublin, Ireland. As of November 15, 2023, Mural Oncology Plc operates as a former subsidiary of Alkermes plc.

Thu, 19 Sep 2024
Primecap Management Co. CA Buys New Holdings in Mural Oncology plc (NASDAQ:MURA) - Defense World

Tue, 17 Sep 2024
Acadian Asset Management LLC Invests $998,000 in Mural Oncology plc (NASDAQ:MURA) - MarketBeat

Tue, 17 Sep 2024
Acadian Asset Management LLC Buys Shares of 318,536 Mural Oncology plc (NASDAQ:MURA) - Defense World

Tue, 10 Sep 2024
Mural Oncology to Host First Virtual Investor Day on September 26, 2024 - StockTitan

Tue, 13 Aug 2024
Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress - StockTitan

Fri, 17 Nov 2023
Why Is Mural Oncology (MURA) Stock Up 59% Today? - InvestorPlace

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	17 (M)
Shares Float	14 (M)
Held by Insiders	2.4 (%)
Held by Institutions	71.1 (%)
Shares Short	494 (K)
Shares Short P.Month	445 (K)

EPS	-10.24
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	12.09
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-81.1 %
Return on Equity (ttm)	-178.4 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-9.89
Qtrly Earnings Growth	0 %
Operating Cash Flow	-160 (M)
Levered Free Cash Flow	-92 (M)

PE Ratio	-0.34
PEG Ratio	0
Price to Book value	0.28
Price to Sales	0
Price to Cash Flow	-0.37

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.